Sentiment-Signal
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 15.12.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers |
| 14.11.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers |
| 02.04.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 7.01 Regulation FD Disclosure As noted under Item 5.02 above, on April 2, 2025, the Company issued a press release anno |
Stammdaten
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.
Unternehmen & Branche
| Name | Enovis CORP |
|---|---|
| Ticker | ENOV |
| CIK | 0001420800 |
| Boerse | US |
| Sektor | Industrials |
| Industrie | Industrial - Machinery |
| SIC | 3842 · Orthopedic, Prosthetic & Surgical Appliances & Supplies |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 1,32 Mrd. USD |
| Beta | 1,59 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 2,248,049,000 | -1,184,440,000 | -20.75 | 3,834,737,000 | 1,489,645,000 |
| 2025-10-03 | 10-Q | 548,912,000 | -571,146,000 | -9.99 | 4,433,367,000 | 2,020,680,000 |
| 2025-07-04 | 10-Q | 564,545,000 | -36,739,000 | -0.64 | 5,021,398,000 | 2,578,187,000 |
| 2025-04-04 | 10-Q | 558,834,000 | -55,966,000 | -0.98 | 4,875,034,000 | 2,617,768,000 |
| 2024-12-31 | 10-K | 2,107,623,000 | -825,494,000 | -14.93 | 4,718,777,000 | 2,562,262,000 |
| 2024-09-27 | 10-Q | 505,222,000 | -31,521,000 | -0.58 | 5,550,141,000 | 3,330,416,000 |
| 2024-06-28 | 10-Q | 525,160,000 | -18,638,000 | -0.34 | 5,442,028,000 | 3,286,414,000 |
| 2024-03-29 | 10-Q | 516,266,000 | -71,998,000 | -1.32 | 5,478,681,000 | 3,308,427,000 |
| 2023-12-31 | 10-K | 1,707,197,000 | -33,261,000 | -0.61 | 4,509,334,000 | 3,418,392,000 |
| 2023-09-29 | 10-Q | 417,524,000 | -2,880,000 | -0.05 | 4,400,917,000 | 3,439,622,000 |
| 2023-06-30 | 10-Q | 428,502,000 | -9,995,000 | -0.18 | 4,443,553,000 | 3,448,638,000 |
| 2023-03-31 | 10-Q | 406,151,000 | -23,350,000 | -0.43 | 4,299,586,000 | 3,443,339,000 |
| 2022-12-31 | 10-K | 408,713,000 | -13,292,000 | -0.71 | 4,273,248,000 | 3,448,085,000 |
| 2022-09-30 | 10-K | 383,814,000 | -1.23 | |||
| 2022-09-30 | 10-Q | 383,814,000 | -66,612,000 | -1.23 | 4,444,818,000 | 3,406,691,000 |
| 2022-07-01 | 10-K | 395,117,000 | 1.41 | |||
| 2022-07-01 | 10-Q | 395,117,000 | 76,855,000 | 1.41 | 4,503,715,000 | 3,489,267,000 |
| 2022-04-01 | 10-K | 375,457,000 | 0.28 | |||
| 2022-04-01 | 10-Q | 1,023,368,000 | 15,068,000 | 0.28 | 8,483,651,000 | 4,600,036,000 |
| 2021-12-31 | 10-K | 399,058,000 | 71,657,000 | -0.04 | 8,515,912,000 | 4,617,378,000 |
Fondsaktivität (Vorquartalsvergleich)
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-10 | Engert Oliver | Officer, Chief Administrative Officer | Open Market Purchase | 1,000 | 23.93 | 23,930.00 | +40,8% | |
| 2026-03-09 | Engert Oliver | Officer, Chief Administrative Officer | Open Market Purchase | 1,000 | 23.39 | 23,390.00 | +39,9% | |
| 2026-03-06 | Engert Oliver | Officer, Chief Administrative Officer | Open Market Purchase | 250 | 24.28 | 6,070.00 | +10,4% | |
| 2026-03-06 | Engert Oliver | Officer, Chief Administrative Officer | Open Market Purchase | 500 | 24.48 | 12,240.00 | +20,9% | |
| 2026-03-04 | Engert Oliver | Officer, Chief Administrative Officer | Open Market Purchase | 250 | 25.10 | 6,275.00 | +10,7% | |
| 2026-03-03 | Engert Oliver | Officer, Chief Administrative Officer | Open Market Purchase | 1,000 | 24.77 | 24,770.00 | +42,3% | |
| 2026-02-27 | Engert Oliver | Officer, Chief Administrative Officer | Open Market Purchase | 1,000 | 25.50 | 25,500.00 | +43,5% | |
| 2025-08-22 | Tandy Bradley J | Officer, SVP and Chief Legal Officer | Open Market Purchase | 3,200 | 31.41 | 100,512.00 | +171,5% | |
| 2025-08-20 | BERRY PHILLIP BENJAMIN (BEN) | Officer, SVP, Chief Financial Officer | Open Market Purchase | 2,500 | 29.71 | 74,275.00 | +126,8% | |
| 2025-08-13 | PRYOR DANIEL A | Officer, EVP, Strategy & Business Dev. | Open Market Purchase | 10,000 | 28.90 | 289,000.00 | +493,2% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.